BOT 1.37% 36.0¢ botanix pharmaceuticals ltd

Ann: Investor Presentation, page-42

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 164 Posts.
    lightbulb Created with Sketch. 26

    Atopic Dermatitis (AD) Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global atopic dermatitis (AD) treatment market was valued at US$ 4.04 Bn in 2016, and is expected to reach US$ 7.66 Bn by 2025, expanding at a CAGR of 7.4% from 2017 to 2025.

    Psoriasis Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global Psoriasis Treatment market was valued at US$ 7.9 Bn in 2016, and is expected to reach US$ 12.8 Bn by 2025, expanding at a CAGR of 5.4% from 2017 to 2025.

    The Global Topical Use Acne Treatment Market is expected to exceed more than US $3 Billion by 2022 at a CAGR of 3% in the given forecast period


    "The Antibacterial Drugs market is expected to cross US$38 Billion by 2023 growing at a CAGR of 1.30% during the given forecast period."


    Botanix Pharmaceuticals' future is looking healthy if phase two results are positive.

 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
36.0¢
Change
-0.005(1.37%)
Mkt cap ! $707.4M
Open High Low Value Volume
36.5¢ 37.0¢ 36.0¢ $391.8K 1.080M

Buyers (Bids)

No. Vol. Price($)
3 160000 35.5¢
 

Sellers (Offers)

Price($) Vol. No.
36.0¢ 11013 2
View Market Depth
Last trade - 16.10pm 29/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.